ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1591125

This article is part of the Research TopicExploring immune low-response states through single-cell technologies and spatial transcriptomicsView all 3 articles

Dissecting the Endothelial Cell Landscape in Meningioma: Single-Cell Insights into PLVAP+ Subpopulations and Their Role in Tumor Angiogenesis

Provisionally accepted
  • 1Department of Neurosurgery, Shanghai Pudong Hospital, Fudan University, Shanghai, Shanghai Municipality, China
  • 2First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
  • 3China Institute of Sport and Health Science, Beijing Sport University, Beijing, China

The final, formatted version of the article will be published soon.

Background: Meningioma (MEN) is one of the most common intracranial tumors, with a significantly higher incidence rate in females than in males. Although the majority of cases are benign, tumors located in complex anatomical regions or classified as atypical or malignant have a high recurrence rate, underscoring the need to optimize therapeutic strategies to improve patient outcomes. Therefore, this study utilizes single-cell RNA-sequencing technology to investigate the interaction mechanisms between endothelial cells (ECs) and meningiomas, aiming to identify potential therapeutic targets for the treatment of MEN patients.Methods:Tissue origin analysis of different EC subpopulations was performed using Ro/e preference analysis. Gene Ontology and Gene Set Enrichment Analysis were employed to enrich and identify relevant biological processes. Slingshot and CytoTRACE were used to determine the differentiation trajectories of cell subpopulations. CellChat was utilized to predict intercellular communication between EC subpopulations and meningioma cells (MGCs). The transcription factor (TF) networks of EC subpopulations were constructed using pySCENIC, and the function of ETS1 was validated in vitro experiments.Results:The MEN and temporal lobe tissues’ datasets were processed through quality control and screening, and dimensionality reduction clustering identified eight cell types. We found that ECs might play a role in MEN progression and further classified them into four subpopulations. Among these, the C2 PLVAP+ ECs were predominantly located at the later stages of differentiation in the Slingshot analysis, suggesting a critical role in MEN’s development. Cell communication analysis revealed that MGCs might stimulate ECs to secrete angiopoietin via the MDK-NCL ligand-receptor pair, promoting angiogenesis and MEN’s progression. Using pySCENIC analysis, the key TF ETS1 was identified. In vitro experiments demonstrated that ETS1 promoted ECs angiogenesis, proliferation, and migration, providing valuable insights for clinical strategies targeting MEN’s treatment.Conclusion:We identified a key ECs subpopulation, C2 PLVAP+ ECs, which was at a critical stage of MEN progression and might influence MEN development through the MK signaling pathway via the MDK-NCL ligand-receptor pair. Additionally, we discovered the critical TF ETS1 and validated through in vitro experiments that it promoted MEN’s progression, offering a new perspective for clinical treatment strategies.

Keywords: Single-cell RNA-sequencing, Meningioma, tumor heterogeneity, ETS1, Angiogenesis

Received: 10 Mar 2025; Accepted: 05 May 2025.

Copyright: © 2025 Zhao, Jia, Xiahou, Ren, Song, Xu, Wang and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hongling Jia, First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
Jin Xing, Department of Neurosurgery, Shanghai Pudong Hospital, Fudan University, Shanghai, 200032, Shanghai Municipality, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.